2024 NFID Annual News Conference: Preventing Respiratory Disease This Fall and Winter

Leading national infectious disease experts presented final respiratory vaccine coverage data from the 2023-2024 US respiratory season and discussed the importance of vaccination against flu, respiratory syncytial disease (RSV), COVID-19, and pneumococcal disease, particularly among older adults, pregnant women, and those with chronic health conditions who are at higher risk for related complications.

Results from an NFID national survey of US adults on vaccination attitudes and behaviors were highlighted at the 2024 National Foundation for Infectious Diseases (NFID) Annual News Conference on Wednesday, September 25, 2024, at 9:00 AM ET.

NFID Medical Director Robert (Bob) H. Hopkins, Jr., MD, moderated the panel discussion with experts including Mandy K. Cohen, MD, MPH, Director, Centers for Disease Control and Prevention (CDC); Demetre C. Daskalakis, MD, MPH, Director, National Center for Immunization and Respiratory Diseases, CDC;  Flor M. Muñoz, MD, MSc, Associate Professor of Pediatrics, Infectious Diseases, Baylor College of Medicine and NFID Director; and Reed V. Tuckson, MD, Co-Founder of the Black Coalition Against COVID and Chair of the Board of the Coalition For Trust In Health & Science.

View media coverage highlights and partner resources